文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于脂质的纳米载体的表面修饰:一种增强靶向药物递送的潜在方法。

Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery.

作者信息

Priya Sakshi, Desai Vaibhavi Meghraj, Singhvi Gautam

机构信息

Industrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science (BITS) - Pilani, Pilani Campus, Pilani, Rajasthan 333031, India.

出版信息

ACS Omega. 2022 Dec 20;8(1):74-86. doi: 10.1021/acsomega.2c05976. eCollection 2023 Jan 10.


DOI:10.1021/acsomega.2c05976
PMID:36643539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9835629/
Abstract

Nanocarriers have the utmost significance for advancements in drug delivery and nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based nanocarriers, viral nanoparticles, or inorganic nanoparticles, depending on their constituent parts. Lipid-based nanocarrier systems have gained tremendous attention over the years because of their noteworthy properties like high drug-loading capacity, lower toxicity, better bioavailability and biocompatibility, stability in the gastrointestinal tract, controlled release, simpler scale-up, and validation process. Nanocarriers still have some disadvantages like poor drug penetration, limited drug encapsulation, and poor targeting. These disadvantages can be overcome by their surface modification. Surface-modified nanocarriers result in controlled release, enhanced penetration efficiency, and targeted medication delivery. In this review, the authors summarize the numerous lipid-based nanocarriers and their functionalization through various surface modifiers such as polymers, ligands, surfactants, and fatty acids. Recent examples of newly developing surface-modified lipid-based nanocarrier systems from the available literature, along with their applications, have been compiled in this work.

摘要

纳米载体对药物递送和纳米医学技术的进步具有极其重要的意义。根据其组成部分,它们可分为基于聚合物的纳米载体、基于脂质的纳米载体、病毒纳米颗粒或无机纳米颗粒。多年来,基于脂质的纳米载体系统因其具有诸如高载药量、低毒性、更好的生物利用度和生物相容性、在胃肠道中的稳定性、控释、更简单的放大和验证过程等显著特性而备受关注。纳米载体仍然存在一些缺点,如药物穿透性差、药物包封受限和靶向性差。这些缺点可以通过其表面修饰来克服。表面修饰的纳米载体可实现控释、提高渗透效率和靶向药物递送。在这篇综述中,作者总结了众多基于脂质的纳米载体及其通过各种表面修饰剂(如聚合物、配体、表面活性剂和脂肪酸)进行的功能化。本文从现有文献中收集了新开发的表面修饰的基于脂质的纳米载体系统的最新实例及其应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/b997f4d3ed24/ao2c05976_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/77dab88dfb6c/ao2c05976_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/ebc97baf1076/ao2c05976_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/63e2314e1e57/ao2c05976_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/3c5d35f17074/ao2c05976_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/b997f4d3ed24/ao2c05976_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/77dab88dfb6c/ao2c05976_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/ebc97baf1076/ao2c05976_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/63e2314e1e57/ao2c05976_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/3c5d35f17074/ao2c05976_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be19/9835629/b997f4d3ed24/ao2c05976_0005.jpg

相似文献

[1]
Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery.

ACS Omega. 2022-12-20

[2]
Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.

Expert Opin Drug Deliv. 2021-2

[3]
Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.

Acta Biomater. 2017-10-14

[4]
Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics.

J Control Release. 2017-12-19

[5]
Current approaches in lipid-based nanocarriers for oral drug delivery.

Drug Deliv Transl Res. 2021-4

[6]
Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.

Acc Chem Res. 2013-2-6

[7]
Application of organic nanocarriers for intraocular drug delivery.

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023-6-25

[8]
Surface Modified Multifunctional and Stimuli Responsive Nanoparticles for Drug Targeting: Current Status and Uses.

Int J Mol Sci. 2016-8-31

[9]
Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.

J Control Release. 2020-5-10

[10]
Recent Progress in Transdermal Nanocarriers and Their Surface Modifications.

Molecules. 2021-5-21

引用本文的文献

[1]
Inhalable Nanomaterial Discoveries for Lung Cancer Therapy: A Review.

Pharmaceutics. 2025-7-31

[2]
Lipid-Based Nanotechnologies for Delivery of Green Tea Catechins: Advances, Challenges, and Therapeutic Potential.

Pharmaceutics. 2025-7-30

[3]
Impact of PEGylation and hyaluronan functionalization on lipoplex-mediated mRNA delivery to the canine retina.

Drug Deliv. 2025-12

[4]
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.

AAPS PharmSciTech. 2025-7-23

[5]
DFT and Molecular Docking Study of HA-Conjugated SWCNTs for CD44-Targeted Delivery of Platinum-Based Chemotherapeutics.

Pharmaceuticals (Basel). 2025-5-27

[6]
Nanotechnology in oncology: advances in biosynthesis, drug delivery, and theranostics.

Discov Oncol. 2025-6-21

[7]
Advances in constructing biocompatible nanocarriers.

Drug Deliv Transl Res. 2025-6-18

[8]
Preparation and characteristics evaluation of chitosan-coated nanoliposomes containing ferrous sulfate.

Sci Rep. 2025-5-31

[9]
Lipid-based nano-carriers for the delivery of anti-obesity natural compounds: advances in targeted delivery and precision therapeutics.

J Nanobiotechnology. 2025-5-7

[10]
Transformative Impact of Nanocarrier-Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons.

Small Sci. 2024-9-17

本文引用的文献

[1]
Design and development of chitosan-insulin-transfersomes (Transfersulin) as effective intranasal nanovesicles for the treatment of Alzheimer's disease: In vitro, in vivo, and ex vivo evaluations.

Biomed Pharmacother. 2022-9

[2]
Polysaccharide-based nanofibers for pharmaceutical and biomedical applications: A review.

Int J Biol Macromol. 2022-10-1

[3]
Pentapeptide modified ethosomes for enhanced skin retention and topical efficacy activity of indomethacin.

Drug Deliv. 2022-12

[4]
Assessment of hyaluronic acid-modified imatinib mesylate cubosomes through CD44 targeted drug delivery in NDEA-induced hepatic carcinoma.

Int J Pharm. 2022-6-25

[5]
Cubosomes with surface cross-linked chitosan exhibit sustained release and bioavailability enhancement for vinpocetine.

RSC Adv. 2019-2-21

[6]
Nanocarriers for ocular drug delivery: current status and translational opportunity.

RSC Adv. 2020-7-24

[7]
Surface-Modified Bilosomes Nanogel Bearing a Natural Plant Alkaloid for Safe Management of Rheumatoid Arthritis Inflammation.

Pharmaceutics. 2022-3-3

[8]
Cubosomes and Hexosomes as Novel Nanocarriers for Bioactive Compounds.

J Agric Food Chem. 2022-2-9

[9]
PEGylated Liposomes Remotely Loaded with the Combination of Doxorubicin, Quinine, and Indocyanine Green Enable Successful Treatment of Multidrug-Resistant Tumors.

Pharmaceutics. 2021-12-17

[10]
Revisiting techniques to evaluate drug permeation through skin.

Expert Opin Drug Deliv. 2021-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索